TNFSF18 and neoplasm: In contrast, the GITRL reverse signaling in APCs and tumor cells was reported to promote some tolerogenic effects, including the release of TGF-beta, IL-10, and induction of indoleamine 2,3-dioxygenase (IDO) for tryptophan catabolism [14, 15, 22].